The differential analysis results indicate that compared to healthy controls, CILP2 is upregulated in the peripheral blood of RA patients, while HAPLN4, FCRL3, EHBP1, and TNFAIP3 are downregulated (S6 Table). This evidence concerns the gene CILP2 and rheumatoid arthritis.